Dr Saxena Integrative Medicine Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -40.41%
- Profit Growth 68.12%
- Ebitda -91.21%
- Net Worth -12.29%
- Total Assets -9.68%
About Dr Saxena Integrative Medicine
Dr Saxena Integrative Medicine Private Limited (DSIMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 14 March 2017 (Seven years and ten months 27 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Monica Saxena and Praveen Saxena serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85320TG2017PTC115866
-
Company No.
115866
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Mar 2017
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Dr Saxena Integrative Medicine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Saxena
|
Director | 14-Mar-2017 | Current |
|
Monica Saxena
|
Director | 14-Mar-2017 | Current |
Financial Performance of Dr Saxena Integrative Medicine.
Dr Saxena Integrative Medicine Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.41% decrease. The company also saw a substantial improvement in profitability, with a 68.12% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Saxena Integrative Medicine?
In 2020, Dr Saxena Integrative Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Saxena Integrative Medicine?
Dr Saxena Integrative Medicine has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Saxena Integrative Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Saxena Integrative Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.